From May 31, 2023 to February 26, 2024, the company has repurchased 56,975,656 shares, representing 4.37% for $53.34 million. With this, the company has completed the repurchase of 56,975,656 shares, representing 4.37% for $53.34 million under the buyback announced on May 31, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.836 USD | -0.24% | -1.18% | -0.48% |
May. 02 | BioPharma Credit Enters $400 Million Loan Agreement with Novocure Luxembourg | MT |
May. 02 | BioPharma Credit agrees USD400 million loan for oncology firm Novacure | AN |
1st Jan change | Capi. | |
---|---|---|
-0.48% | 1.02B | |
+7.69% | 13.26B | |
+11.85% | 9.55B | |
+2.65% | 5.74B | |
+7.30% | 5.27B | |
-0.71% | 5.11B | |
+26.36% | 4.99B | |
+20.18% | 4.59B | |
+5.29% | 3.97B | |
+1.45% | 3.98B |
- Stock Market
- Equities
- BPCP Stock
- News BioPharma Credit PLC
- Tranche Update on BioPharma Credit PLC's Equity Buyback Plan announced on May 31, 2023.